1. CMX-2043 Efficacy in a Rat Model of Cardiac Ischemia–Reperfusion Injury. (November 2016) Authors: Baguisi, Alexander; Casale, Ralph A.; Kates, Steven A.; Lader, Alan S.; Stewart, Kenneth; Beeuwkes, Reinier Journal: Journal of cardiovascular pharmacology and therapeutics Issue: Volume 21:Number 6(2016:Nov.) Page Start: 563 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CMX-2043 Mechanisms of Action In Vitro. Issue 3 (September 2016) Authors: Lader, Alan S.; Baguisi, Alexander; Casale, Ralph; Kates, Steven A.; Beeuwkes, Reinier Journal: Journal of cardiovascular pharmacology Issue: Volume 68:Issue 3(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pre‐clinical and Clinical Safety Studies of CMX‐2043: A Cytoprotective Lipoic Acid Analogue for Ischaemia–Reperfusion Injury. (16th May 2014) Authors: Kates, Steven A.; Lader, Alan S.; Casale, Ralph; Beeuwkes, Reinier Journal: Basic & clinical pharmacology & toxicology Issue: Volume 115:Number 5(2014:May) Page Start: 456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SUPPORT-1 (Subjects Undergoing PCI and Perioperative Reperfusion Treatment): A Prospective, Randomized Trial of CMX-2043 in Patients Undergoing Elective Percutaneous Coronary Intervention. Issue 2 (August 2020) Authors: Tcheng, James E.; Gibson, Michael; Krucoff, Mitchell W.; Patel, Manesh R.; Ajit, Mullasari; Hiremath, Jagdish; Ponde, Chandrashekhar; Ramsaran, Eddison; Clark, Geoffrey; Lader, Alan S.; Beeuwkes, Reinier Journal: Journal of cardiovascular pharmacology Issue: Volume 76:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗